Physicochemical Properties
| Molecular Formula | C129H206F3N37O42 |
| Molecular Weight | 3004.27 |
| Related CAS # | AC 187;151804-77-2 |
| Appearance | White to off-white solid powder |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | IC50: 0.48 nM (amylin receptor) |
| ln Vitro | Amyloidβ protein (Aβ)-induced neurotoxicity is inhibited by AC 187. The neuronal survival of cultures treated with AC 187 prior to exposure to Aβ is markedly enhanced[1]. Aβ-induced apoptotic cell death is mediated by initiator and effector caspases, both of which are attenuated by AC187[1]. |
| ln Vivo | In hyperinsulinemic clamps in Sprague-Dawley (HSD) rats, AC 187 (30 mg/mL) raises glucagon levels, speeds up gastric emptying of liquids, and causes an inflated post-challenge glycemia[2]. |
| References |
[1]. Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci. 2004 Jun 16;24(24):5579-84. [2]. Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Regul Pept. 2006 Dec 10;137(3):121-7. |
Solubility Data
| Solubility (In Vitro) | H2O :~100 mg/mL (~33.29 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (33.29 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.3329 mL | 1.6643 mL | 3.3286 mL | |
| 5 mM | 0.0666 mL | 0.3329 mL | 0.6657 mL | |
| 10 mM | 0.0333 mL | 0.1664 mL | 0.3329 mL |